Efficacy of adjuvant chemotherapy for non-small cell lung cancer assessed by metastatic potential associated with ACTN4

Although several clinical trials have demonstrated the benefits of platinum-combined adjuvant chemotherapy for resected non-small cell lung cancer (NSCLC), predictive biomarkers for the efficacy of such therapy have not yet been identified. Selection of patients with high metastatic ability in the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Miura, Nami, Kamita, Masahiro, Kakuya, Takanori, Fujiwara, Yutaka, Tsuta, Koji, Shiraishi, Hideaki, Takeshita, Fumitaka, Ochiya, Takahiro, Shoji, Hirokazu, Huang, Wilber, Ohe, Yuichiro, Yamada, Tesshi, Honda, Kazufumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078083/
https://www.ncbi.nlm.nih.gov/pubmed/27121206
http://dx.doi.org/10.18632/oncotarget.8890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078083/
https://www.ncbi.nlm.nih.gov/pubmed/27121206
http://dx.doi.org/10.18632/oncotarget.8890

Ejemplares similares